First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 180.35 USD 0.65% Market Closed
Updated: Mar 28, 2024

Abbvie Inc
Total Current Liabilities

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
|

Abbvie Inc
Total Current Liabilities Peer Comparison

Comparables:
GILD
AMGN
VRTX
REGN
SGEN

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Total Current Liabilities
$37.8B
CAGR 3-Years
10%
CAGR 5-Years
17%
CAGR 10-Years
19%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Liabilities
$11.3B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
6%
Amgen Inc
NASDAQ:AMGN
Total Current Liabilities
$18.4B
CAGR 3-Years
16%
CAGR 5-Years
6%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Liabilities
$3.5B
CAGR 3-Years
24%
CAGR 5-Years
26%
CAGR 10-Years
24%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Liabilities
$3.4B
CAGR 3-Years
8%
CAGR 5-Years
19%
CAGR 10-Years
28%
Seagen Inc
NASDAQ:SGEN
Total Current Liabilities
$954.7m
CAGR 3-Years
17%
CAGR 5-Years
38%
CAGR 10-Years
25%

See Also

What is Abbvie Inc's Total Current Liabilities?
Total Current Liabilities
37.8B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Total Current Liabilities amounts to 37.8B USD.

What is Abbvie Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
19%

Over the last year, the Total Current Liabilities growth was 28%. The average annual Total Current Liabilities growth rates for Abbvie Inc have been 10% over the past three years , 17% over the past five years , and 19% over the past ten years .